Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
405 results
  • Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms. [Review]
    Microorganisms 2019; 7(8)Koulenti D, Xu E, … Tsiodras S
  • Increasing multidrug-resistance to Gram-positive pathogens, particularly to staphylococci, enterococci and streptococci, is a major problem, resulting in significant morbidity, mortality and healthcare costs. In recent years, only a small number of novel antibiotics effective against Gram-positive bacteria has been approved. This review will discuss the current evidence for novel branded antibiot…
  • Real-world use of telavancin in the treatment of osteomyelitis. [Journal Article]
    Diagn Microbiol Infect Dis 2019; 95(2):185-190Saravolatz LD, Cleveland KO, … Szpunar S
  • This is a retrospective analysis of patients with osteomyelitis who received telavancin at some time during their treatment course. The primary outcome was the percent of patients cured or improved at the end of telavancin therapy (EOTT). The secondary outcome was the percent of patients cured or improved three months after discontinuation of telavancin therapy. There were 32 cases of osteomyelit…
New Search Next